{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T01:32:58Z","timestamp":1726191178776},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Malignant mesothelioma is an aggressive, treatment-resistant tumor arising from mesothelium of pleura, peritoneum and pericardium. Despite current combined regimen, its prognosis remains dismal, calling for more effective targeted therapies. We investigated whether aberrant Hh activation may play a role in mesothelioma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>SMO and SHH expression levels were analyzed in 46 mesothelioma tissue specimens with real-time RT-PCR, and correlation with survival was analyzed with univariate and multivariate Cox proportional hazards models, Kaplan-Meier survival curves, and the log-rank test. We also examined multiple mesothelioma cell lines for SMO expression and the effect of Hh inhibition by a specific SMO antagonist on cell proliferation by MTS assay.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We observed strong correlation between higher SMO and SHH expression levels with poorer overall survival. Remarkably, Hh inhibition by a specific SMO inhibitor significantly suppressed cell proliferation in the mesothelioma cell lines examined.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our data strongly support that Hh signaling deregulation plays critical roles in proliferation of mesothelioma, and consistently exerts significant impact on prognosis of the disease. Therefore our findings revealed the hitherto unappreciated role of Hh activation in mesothelioma, and pinpointed Hh signaling antagonist as a potential new therapy against this devastating disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1756-9966-32-7","type":"journal-article","created":{"date-parts":[[2013,2,5]],"date-time":"2013-02-05T01:14:36Z","timestamp":1360026876000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["SMO expression level correlates with overall survival in patients with malignant pleural mesothelioma"],"prefix":"10.1186","volume":"32","author":[{"given":"Yi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianxing","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongsheng","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M","family":"Jablons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biao","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Lui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,5]]},"reference":[{"issue":"3","key":"654_CR1","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2486\/indhealth.45.379","volume":"45","author":"C Bianchi","year":"2007","unstructured":"Bianchi C, Bianchi T: Malignant mesothelioma: global incidence and relationship with asbestos. Ind Health. 2007, 45 (3): 379-387. 10.2486\/indhealth.45.379.","journal-title":"Ind Health"},{"issue":"9483","key":"654_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","volume":"366","author":"BW Robinson","year":"2005","unstructured":"Robinson BW, Musk AW, Lake RA: Malignant mesothelioma. Lancet. 2005, 366 (9483): 397-408. 10.1016\/S0140-6736(05)67025-0. Review","journal-title":"Lancet"},{"issue":"1","key":"654_CR3","first-page":"70","volume":"12","author":"FE Mott","year":"2012","unstructured":"Mott FE: Mesothelioma: a review. Ochsner J. 2012, 12 (1): 70-79.","journal-title":"Ochsner J"},{"issue":"4","key":"654_CR4","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1378\/chest.108.4.1122","volume":"108","author":"VW Rusch","year":"1995","unstructured":"Rusch VW: A proposed new international TNM staging system for malignant pleural mesothelioma. Chest. 1995, 108 (4): 1122-1128.","journal-title":"Chest"},{"issue":"2","key":"654_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1165\/rcmb.2009-0206TR","volume":"42","author":"NH Heintz","year":"2010","unstructured":"Heintz NH, Janssen-Heininger YM, Mossman BT: Asbestos, lung cancers, and mesotheliomas: from molecular approaches to targeting tumor survival pathways. Am J Respir Cell Mol Biol. 2010, 42 (2): 133-139. 10.1165\/rcmb.2009-0206TR. Review","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"654_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1349-7006.2009.01336.x","volume":"101","author":"Y Sekido","year":"2010","unstructured":"Sekido Y: Genomic abnormalities and signal transduction dysregulation in malignant mesothelioma cells. Cancer Sci. 2010, 101 (1): 1-6. 10.1111\/j.1349-7006.2009.01336.x.","journal-title":"Cancer Sci"},{"issue":"6B","key":"654_CR7","first-page":"4239","volume":"27","author":"K Uematsu","year":"2007","unstructured":"Uematsu K, Seki N, Seto T, Isoe C, Tsukamoto H, Mikami I, You L, He B, Xu Z, Jablons DM, Eguchi K: Targeting the Wnt signaling pathway with dishevelled and cisplatin synergistically suppresses mesothelioma cell growth. Anticancer Res. 2007, 27 (6B): 4239-4242.","journal-title":"Anticancer Res"},{"issue":"17","key":"654_CR8","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1158\/1078-0432.CCR-12-0599","volume":"18","author":"Y Shi","year":"2012","unstructured":"Shi Y, Moura U, Opitz I, Soltermann A, Rehrauer H, Thies S, Weder W, Stahel RA, Felley-Bosco E: Role of hedgehog signaling in malignant pleural mesothelioma. Clin Cancer Res. 2012, 18 (17): 4646-4656. 10.1158\/1078-0432.CCR-12-0599.","journal-title":"Clin Cancer Res"},{"key":"654_CR9","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1101\/gad.1693608","volume":"22","author":"M Varjosalo","year":"2008","unstructured":"Varjosalo M, Taipale J: Hedgehog: functions and mechanisms. Genes Dev. 2008, 22: 2454-2472. 10.1101\/gad.1693608.","journal-title":"Genes Dev"},{"key":"654_CR10","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/onc.2009.392","volume":"29","author":"L Yang","year":"2010","unstructured":"Yang L, Xie G, Fan Q, Xie J: Activation of the hedgehog-signaling pathway in human cancer and the clinical implications. Oncogene. 2010, 29: 469-481. 10.1038\/onc.2009.392.","journal-title":"Oncogene"},{"key":"654_CR11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.tips.2009.03.007","volume":"30","author":"SJ Scales","year":"2009","unstructured":"Scales SJ, de Sauvage FJ: Mechanisms of Hedgehog pathway activation in cancer and implications for therapy. Trends Pharmacol Sci. 2009, 30: 303-312. 10.1016\/j.tips.2009.03.007.","journal-title":"Trends Pharmacol Sci"},{"key":"654_CR12","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1093\/carcin\/bgi130","volume":"26","author":"X Ma","year":"2005","unstructured":"Ma X, Chen K, Huang S: Frequent activation of the hedgehog pathway in advanced gastric adenocarcinomas. Carcinogenesis. 2005, 26: 1698-1705. 10.1093\/carcin\/bgi130.","journal-title":"Carcinogenesis"},{"key":"654_CR13","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nrm1622","volume":"6","author":"JE Hooper","year":"2005","unstructured":"Hooper JE, Scott MP: Communicating with Hedgehogs. Nat Rev Mol Cell Biol. 2005, 6: 306-317. 10.1038\/nrm1622.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"654_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1242\/dev.02169","volume":"133","author":"D Huangfu","year":"2006","unstructured":"Huangfu D, Anderson KV: Signaling from Smo to Ci\/ Gli: conservation and divergence of Hedgehog pathways from Drosophila to vertebrates. Development. 2006, 133: 3-14. 10.1242\/dev.02169.","journal-title":"Development"},{"key":"654_CR15","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.tcb.2006.02.004","volume":"16","author":"T Osterlund","year":"2006","unstructured":"Osterlund T, Kogerman P: Hedgehog signalling: how to go from Smo to Ci and Gli. Trends Cell Biol. 2006, 16: 176-180. 10.1016\/j.tcb.2006.02.004.","journal-title":"Trends Cell Biol"},{"key":"654_CR16","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrc796","volume":"2","author":"A Ruiz i Altaba","year":"2002","unstructured":"Ruiz i Altaba A, Sanchez P, Dahmane N: Gli and hedgehog in cancer: tumors, embryos and stem cells. Nat Rev Cancer. 2002, 2: 361-372. 10.1038\/nrc796.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"654_CR17","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.bbrc.2012.07.136","volume":"425","author":"X Bi","year":"2012","unstructured":"Bi X, Han X, Zhang F, He M, Zhang Y, Zhi XY, Zhao H: Triparanol suppresses human tumor growth in vitro and in vivo. Biochem Biophys Res Commun. 2012, 425 (3): 613-618. 10.1016\/j.bbrc.2012.07.136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"35","key":"654_CR18","doi-asserted-by":"publisher","first-page":"33067","DOI":"10.1074\/jbc.M212635200","volume":"278","author":"F Zhang","year":"2003","unstructured":"Zhang F, Phiel CJ, Spece L, Gurvich N, Klein PS: Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3. J Biol Chem. 2003, 278 (35): 33067-33077. 10.1074\/jbc.M212635200.","journal-title":"J Biol Chem"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-9966-32-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T22:57:47Z","timestamp":1630537067000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/1756-9966-32-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,5]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["654"],"URL":"https:\/\/doi.org\/10.1186\/1756-9966-32-7","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,5]]},"assertion":[{"value":"24 October 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"7"}}